"Understanding the Patient Experience of Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC) in the Immuno-oncology Era"

Administered By

Awarded By

Contributors

Start/End

  • December 10, 2020 - December 31, 2022